Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB08865_nanopub.RAyWcrypg-kIMecVDHVEAQkeR4kRM5Wn5AnID4u8l7310#assertion>. }
Showing items 1 to 21 of
21
with 100 items per page.
- drugbank:DB08865 type drugbank_vocabulary:Drug assertion.
- drugbank:DB08865 label "Crizotinib [drugbank:DB08865]" assertion.
- drugbank:DB08865 seeAlso DB08865 assertion.
- drugbank:DB08865 seeAlso crizotinib.html assertion.
- drugbank:DB08865 seeAlso xalkori-drug.htm assertion.
- drugbank:DB08865 identifier "drugbank:DB08865" assertion.
- drugbank:DB08865 description "Crizotinib an inhibitor of receptor tyrosine kinase for the treatment of non-small cell lung cancer (NSCLC). Verification of the presence of ALK fusion gene is done by Abbott Molecular's Vysis ALK Break Apart FISH Probe Kit. This verification is used to select for patients suitable for treatment. FDA approved in August 26, 2011." assertion.
- drugbank:DB08865 title "Crizotinib" assertion.
- drugbank:DB08865 bio2rdf_vocabulary:identifier "DB08865" assertion.
- drugbank:DB08865 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB08865 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB08865" assertion.
- drugbank:DB08865 bio2rdf_vocabulary:x-identifiers.org DB08865 assertion.
- drugbank:DB08865 drugbank_vocabulary:drugbank-id "DB08865" assertion.
- drugbank:DB08865 drugbank_vocabulary:x-cas cas:877399-52-5 assertion.
- drugbank:DB08865 drugbank_vocabulary:x-ahfs ahfs:10:00 assertion.
- drugbank:DB08865 drugbank_vocabulary:x-atc atc:L01XE16 assertion.
- drugbank:DB08865 drugbank_vocabulary:x-chebi chebi:64310 assertion.
- drugbank:DB08865 drugbank_vocabulary:x-kegg kegg:D09731 assertion.
- drugbank:DB08865 drugbank_vocabulary:x-pharmgkb pharmgkb:PA165946122 assertion.
- drugbank:DB08865 drugbank_vocabulary:x-wikipedia wikipedia:Crizotinib assertion.
- drugbank:DB08865 drugbank_vocabulary:x-ndc ndc:0069-8141-20 assertion.